Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Froidure

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Patient Preference and Adherence|August 10, 2023
I-PreFer Study: A Questionnaire to Explore Patient, Caregiver and Pulmonologist Preferences of Idiopathic Pulmonary Fibrosis Treatment OptionsMaria Hollmen, Tom Bromilow, Adam B Smith, et al.
ERJ Open Research|November 12, 2025
Immunoglobulin A mucosal immunity in people with cystic fibrosis shortly after initiation of highly effective modulator therapyAngélique Mottais, Ziyu Alessia Qiu, Bruno Detry, et al.
Aging|October 26, 2020
Short telomeres increase the risk of severe COVID-19Antoine Froidure, Manon Mahieu, Delphine Hoton, et al.
Lung|July 9, 2025
Use of Telomere Length as a Biomarker in Idiopathic Pulmonary FibrosisCaroline Dahlqvist, Thomas Planté-Bordeneuve, Trejsi Muca, et al.
Frontiers in Medicine|January 28, 2026
Quantification and characterization of lung fibrosis in ARDS patients using picrosirius red stainingLudovic Gerard, Marylene Lecocq, Guillaume Courtoy, et al.
Frontiers in Immunology|February 2, 2026
Hematological complications in solid organ transplant recipients with telomere biology disorders: a narrative reviewFrançois M Carlier, Thomas Planté-Bordeneuve, Antoine Froidure, et al.
Chest|October 2, 2022
Correlation of BAL Cell Count and Pulmonary Function Tests in the Era of Antifibrotics: Data From the Belgium-Luxembourg Idiopathic Pulmonary Fibrosis RegistryAntoine Froidure, Benjamin Bondue, Caroline Dahlqvist, et al.
Patient Preference and Adherence|August 10, 2023
I-PreFer Study: A Discrete Choice Experiment to Explore Patient, Caregiver and Pulmonologist Preferences of Idiopathic Pulmonary Fibrosis Pharmacological Treatment OptionsMaria Hollmen, Marlies Wijsenbeek, Tom Bromilow, et al.
American Journal of Respiratory and Critical Care Medicine|July 8, 2024
The IgA-pIgR System Is Dysregulated in Idiopathic Pulmonary FibrosisThomas Planté-Bordeneuve, Youri Bertrand, Marylène Lecocq, et al.
Particle and Fibre Toxicology|April 25, 2025
Unique transcriptomic responses of rat and human alveolar macrophages in an in vitro model of overload with TiO<sub>2</sub> and carbon blackLaeticia Perez, Jérôme Ambroise, Bertrand Bearzatto, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Patient Preference and Adherence|August 10, 2023
I-PreFer Study: A Questionnaire to Explore Patient, Caregiver and Pulmonologist Preferences of Idiopathic Pulmonary Fibrosis Treatment OptionsMaria Hollmen, Tom Bromilow, Adam B Smith, et al.
ERJ Open Research|November 12, 2025
Immunoglobulin A mucosal immunity in people with cystic fibrosis shortly after initiation of highly effective modulator therapyAngélique Mottais, Ziyu Alessia Qiu, Bruno Detry, et al.
Aging|October 26, 2020
Short telomeres increase the risk of severe COVID-19Antoine Froidure, Manon Mahieu, Delphine Hoton, et al.
Lung|July 9, 2025
Use of Telomere Length as a Biomarker in Idiopathic Pulmonary FibrosisCaroline Dahlqvist, Thomas Planté-Bordeneuve, Trejsi Muca, et al.
Frontiers in Medicine|January 28, 2026
Quantification and characterization of lung fibrosis in ARDS patients using picrosirius red stainingLudovic Gerard, Marylene Lecocq, Guillaume Courtoy, et al.
Frontiers in Immunology|February 2, 2026
Hematological complications in solid organ transplant recipients with telomere biology disorders: a narrative reviewFrançois M Carlier, Thomas Planté-Bordeneuve, Antoine Froidure, et al.
Chest|October 2, 2022
Correlation of BAL Cell Count and Pulmonary Function Tests in the Era of Antifibrotics: Data From the Belgium-Luxembourg Idiopathic Pulmonary Fibrosis RegistryAntoine Froidure, Benjamin Bondue, Caroline Dahlqvist, et al.
Patient Preference and Adherence|August 10, 2023
I-PreFer Study: A Discrete Choice Experiment to Explore Patient, Caregiver and Pulmonologist Preferences of Idiopathic Pulmonary Fibrosis Pharmacological Treatment OptionsMaria Hollmen, Marlies Wijsenbeek, Tom Bromilow, et al.
American Journal of Respiratory and Critical Care Medicine|July 8, 2024
The IgA-pIgR System Is Dysregulated in Idiopathic Pulmonary FibrosisThomas Planté-Bordeneuve, Youri Bertrand, Marylène Lecocq, et al.
Particle and Fibre Toxicology|April 25, 2025
Unique transcriptomic responses of rat and human alveolar macrophages in an in vitro model of overload with TiO<sub>2</sub> and carbon blackLaeticia Perez, Jérôme Ambroise, Bertrand Bearzatto, et al.
Pageof 7